Skip to main content
ULBI
NASDAQ Manufacturing

Ultralife Q2: Record Backlog and Margin Surge, but Material Weakness Lingers

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Electrical Equipment Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$6.35
Mkt Cap
$105.77M
52W Low
$4.9
52W High
$8.25
52W Position info
30% above low
Off High info
23% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

ULBI sits 30% above its 52-week low of $4.9 on elevated volume (2.3× avg).

Summary

Ultralife's Q2 2026 earnings reveal a sharp operational rebound with record backlog and margin gains, but the filing also discloses an ongoing unremediated material weakness in internal controls—a governance red flag.


Key Events · Earnings and Guidance · ULBI

  • Q2 Revenue and Margin Beat

    Revenue of $47.9M, gross margin of 28.9% (up 760 bps sequentially), GAAP EPS of $0.15, and adjusted EBITDA of $6.1M, driven by favorable mix and a $1.1M IEEPA refund.

  • Record Backlog of $117.5M

    Backlog reached an all-time high, up from $115.1M in Q1 2026 and $84.5M a year ago, with Communications Systems revenue surging 39.3% YoY.

  • Material Weakness in Internal Controls

    The concurrently filed 10-Q discloses an ongoing unremediated material weakness in internal controls over financial reporting, a governance concern that persists despite operational improvements.

  • One-Time Costs Impact Earnings

    $0.9M in one-time costs, primarily litigation expenses for a cyber-insurance claim and consulting fees for margin improvement initiatives, weighed on operating income.


Analysis · ULBI · Manufacturing

A sharp operational rebound marked Ultralife's Q2 2026, with gross margin climbing 760 basis points sequentially to 28.9% and adjusted EBITDA reaching $6.1 million. Demand is clearly strengthening, especially in defense, as evidenced by a record $117.5 million backlog and a 39% jump in Communications Systems revenue. Yet the same day's 10-Q discloses an ongoing unremediated material weakness in internal controls—a governance red flag that tempers an otherwise strong quarter. The result is a mixed but net positive picture, with the control deficiency remaining a key risk for investors.

At the time of this filing, ULBI was trading at $6.35 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $105.8M. The 52-week trading range was $4.90 to $8.25. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ULBI - Latest Insights

ULBI
Aug 07, 2026, 7:30 AM EDT
Filing Type: 10-Q
Importance Score:
8
ULBI
Jun 02, 2026, 1:07 PM EDT
Filing Type: DEF 14A
Importance Score:
7
ULBI
May 26, 2026, 4:18 PM EDT
Filing Type: 4
Importance Score:
7
ULBI
May 08, 2026, 7:31 AM EDT
Filing Type: 10-Q
Importance Score:
8
ULBI
May 08, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
8